描述
Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).
种类
Amides
D000577
Heterocyclic Compounds, Fused-Ring
D000072471
Sulfones
D013450
Sulfur Compounds
D013457
Thiazoles
D013844
resource：ChemSpider
identifier：58828074
resource：BindingDB
identifier：50244350
resource：PDB
identifier：BJB
resource：ChEMBL
identifier：CHEMBL4091374